[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
From the JAMA Network
May 23/30, 2017

Evaluating Alternative Payment Models in Oncology

Author Affiliations
  • 1Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
  • 2Associate Editor, JAMA
JAMA. 2017;317(20):2123-2124. doi:10.1001/jama.2017.3028

Cancer care is expensive, and like other chronic illnesses, is prone to waste both through overuse of low-value services and underuse of evidence-based approaches.1 The fee-for-service model has been cited as a major factor, creating perverse incentives to provide high-cost, low-value care without sufficiently monitoring quality.2 Alternative models have been proposed as a means to both control costs and improve quality in oncology, including accountable care organizations, bundled episode-based payment models, and patient-centered medical homes.